These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37218543)

  • 1. Cross-reactive humoral immunity of clade 2 Oka and MAV/06 strain-based varicella vaccines against different clades of varicella-zoster virus.
    Hwang JY; Kim Y; Lee KM; Shin OS; Gim JA; Shin Y; Park H
    Hum Vaccin Immunother; 2023 Dec; 19(1):2210961. PubMed ID: 37218543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological characteristics of MAV/06 strain of varicella-zoster virus vaccine in an animal model.
    Shin D; Shin Y; Kim E; Nam H; Nan H; Lee J
    BMC Immunol; 2022 Jun; 23(1):27. PubMed ID: 35658899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study.
    Choi UY; Kim KH; Lee J; Eun BW; Kim DH; Ma SH; Kim CS; Lapphra K; Tangsathapornpong A; Kosalaraksa P; Oberdorfer P; Kim HM; Shin SM; Kang JH
    Vaccine; 2021 Mar; 39(12):1758-1764. PubMed ID: 33627245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.
    Choi UY; Huh DH; Kim JH; Kang JH
    Hum Vaccin Immunother; 2016 Oct; 12(10):2560-2564. PubMed ID: 27484734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characterization analysis of gM, gL genes of varicella zoster virus in six provinces of China].
    Mou JJ; Qi MY; Li CS; Zheng HY; Chen M; Zhou JH; He JL; Xu WW; Xu ST; Xu XG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):419-423. PubMed ID: 29614611
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
    Wu Q; Rivailler P; Xu S; Xu W
    J Virol; 2019 May; 93(9):. PubMed ID: 30728261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete DNA sequences of two oka strain varicella-zoster virus genomes.
    Tillieux SL; Halsey WS; Thomas ES; Voycik JJ; Sathe GM; Vassilev V
    J Virol; 2008 Nov; 82(22):11023-44. PubMed ID: 18787000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).
    Goulleret N; Mauvisseau E; Essevaz-Roulet M; Quinlivan M; Breuer J
    Vaccine; 2010 Aug; 28(36):5878-82. PubMed ID: 20600487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.
    Takayama M; Takayama N
    J Clin Virol; 2004 Feb; 29(2):113-9. PubMed ID: 14747030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction fragment differences between the genomes of the Oka varicella vaccine virus and American wild-type varicella-zoster virus.
    Adams SG; Dohner DE; Gelb LD
    J Med Virol; 1989 Sep; 29(1):38-45. PubMed ID: 2573686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
    Silber JL; Chan IS; Wang WW; Matthews H; Kuter BJ
    Pediatr Infect Dis J; 2007 Jul; 26(7):572-6. PubMed ID: 17596796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring prevalence of varicella-zoster virus clades in Germany.
    Sauerbrei A; Stefanski J; Philipps A; Krumbholz A; Zell R; Wutzler P
    Med Microbiol Immunol; 2011 May; 200(2):99-107. PubMed ID: 21072536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response of varicella vaccinees to different varicella-zoster virus genotypes.
    Sauerbrei A; Stefanski J; Gruhn B; Wutzler P
    Vaccine; 2011 May; 29(22):3873-7. PubMed ID: 21459174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.
    Berger R; Trannoy E; Holländer G; Bailleux F; Rudin C; Creusvaux H
    J Infect Dis; 1998 Nov; 178 Suppl 1():S99-103. PubMed ID: 9852985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain.
    Hawrami K; Breuer J
    J Med Virol; 1997 Sep; 53(1):60-2. PubMed ID: 9298733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide distribution of varicella-zoster virus clades in China.
    Xu S; Chen M; Zheng H; Wang H; Chen M; Zhou J; Shuang W; Yu P; Ma C; He J; Feng D; Zhen Z; Yan Z; Naiying M; Cui A; Wu Q; Qi M; Li C; Xu X; Xu W
    BMC Infect Dis; 2016 Oct; 16(1):542. PubMed ID: 27717328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
    Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
    Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax.
    Kim JI; Jung GS; Kim YY; Ji GY; Kim HS; Wang WD; Park HS; Park SY; Kim GH; Kwon SN; Lee KM; Ahn JH; Yoon Y; Lee CH
    Virol J; 2011 Dec; 8():547. PubMed ID: 22176950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.